Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
New York University v. Galderma Laboratories, Inc.
Case Number:
1:12-cv-08169
Court:
Nature of Suit:
Judge:
Companies
Sectors & Industries:
-
August 03, 2015
Galderma Owes NYU's Fees For Oracea Appeal, Judge Says
Galderma Laboratories Inc. must cover New York University's attorneys' fees stemming from an appeal of an underlying patent suit against Mylan Pharmaceuticals Inc. and others, a New York federal judge held Friday, even though the dermatology drugmaker didn't bring the appeal.
-
August 15, 2013
Galderma Fights Appeal Fee Bid In NYU Oracea Dispute
Galderma Laboratories Inc. on Wednesday hit back at New York University's bid for it to pay attorneys' fees stemming from an appeal over a decision invalidating patents behind rosacea treatment Oracea, telling a New York federal judge it shouldn't have to pay for litigation it didn't instigate.
-
April 18, 2013
Galderma Must Pay Oracea Fees To NYU During Appeal
A New York federal judge ruled Wednesday that Galderma Laboratories Inc. will have to keep paying royalties to New York University for the patents behind rosacea treatment Oracea while the school appeals a decision that found the patents invalid.